Immediate postoperative care

Cardiology in the Young

Volumn 19, Issue E-SUPP. 1, 2009, Pages 23-27

  Adatia, Ian ^a,c   Beghetti, Maurice ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Congenital heart disease; Nitric oxide; Postoperative intensive care; Pulmonary hypertension; Pulmonary hypertensive crisis

Indexed keywords

BICARBONATE; FENTANYL; ILOPROST; NITRIC OXIDE; OXYGEN; PROSTACYCLIN; SILDENAFIL;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONGENITAL HEART DISEASE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HUMAN; HYPOXIA; LUNG BIOPSY; METHEMOGLOBINEMIA; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; OXYGEN THERAPY; PAIN; POSTOPERATIVE CARE; PULMONARY HYPERTENSION; RISK FACTOR; TREATMENT INDICATION; TRICUSPID VALVE REGURGITATION; CONGENITAL HEART MALFORMATION; INFANT; POSTOPERATIVE COMPLICATION; SWAN GANZ CATHETER; TIME;

CATHETERIZATION, SWAN-GANZ; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TIME FACTORS;

EID: 68949214342     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951109003916     Document Type: Article

References (32)

1. Hopkins RA, Bull C, Haworth SG, de Leval MR, Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991; 5: 628-634.
2. Wheller J, George BL, Mulder DG, Jamarkani JM. Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 1979; 60: 1640-1644.
3. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88[part 1]: 2128-2138.
4. Komai H, Adatia I, Elliott MJ, de Leval MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993; 106: 473-478.
5. Adatia I, Barrow S, Stratton P, Ritter J, Haworth S. Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt. Br Heart J 1994; 72: 452-456.
6. Bando K, Turrentine MW, Sharp TG, et al. Pulmonary hypertension after operations for congenital heart disease: Analysis of risk factors and management. J Thorac Cardiovasc Surg 1996; 112: 1600-1607; discussion 1607-1609.
7. Lindberg L, Olsson AK, Jogi P, Jonmarker C. How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg 2002; 123: 1155-1163.
8. Brown KL, Ridout DA, Goldman AP, Hoskote A, Penny DJ. Risk factors for long intensive care unit stay after cardiopulmonary bypass in children. Crit Care Med 2003; 31: 28-33.
9. Schulze-Neick I, Li J, Penny DJ, Redington AN. Pulmonary vascular resistance after cardiopulmonary bypass in infants: Effect on postoperative recovery. J Thorac Cardiovasc Surg 2001; 121: 1033-1039.
10. Hanley F, Heinemann M, Jonas R, et al. Repair of truncus arteriosus in the neonate. J Thorac Cardiovasc Surg 1993; 105: 1047-1056.
11. Haworth SG. Pulmonary vascular disease in different types of congenital heart disease. Br Heart J 1984; 52: 557-571.
12. Brizard CP, Cochrane A, Austin C, Nomura F, Karl TR. Management strategy and long-term outcome for truncus arteriosus. Eur J Cardiothorac Surg 1997; 11: 687-695; discussion 695-686.
13. Flori HR, Johnson LD, Hanley FL, Fineman JR. Transthoracic intracardiac catheters in pediatric patients recovering from congenital heart defect surgery: Associated complications and outcomes. Crit Care Med 2000; 28: 2997-3001.
14. Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology 1990; 73: 661-670.
15. Anand KJ, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: Effects on the stress response. Lancet 1987; 1 (8524): 62-66.
16. Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit Care Med 2000; 28: 2974-2978.
17. Chang AC, Zucker HA, Hickey PR, Wessel DL. Pulmonary vascular resistance in infants after cardiac surgery: Role of carbon dioxide and hydrogen ion. Crit Care Med 1995; 23: 568-574.
18. Beghetti M, Habre W, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995; 73: 65-68.
19. Miller OI, Celermeyer DS, Deanfield JE, Macrae DJ. Very low dose inhaled nitric oxide: A selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108: 487-494.
20. Journois D, Pouard P, Mauriat P, Malhère T, Vouhé P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994; 107: 1129-1135.
21. Russell IA, Zwass MS, Fineman JR, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 1998; 87: 46-51.
22. Journois D, Baufreton C, Mauriat P, Pouard P, Vouhe P, Safran D. Effects of inhaled nitric oxide administration on early postoperative mortality in patients operated for correction of atrioventricular canal defects. Chest 2005; 128: 3537-3544.
23. Wessel DL, Adatia I, Thompson JE, Hickey PR. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 1994; 22: 930-938.
24. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child 1994; 70: F47-F49.
25. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: A randomised double-blind study. Lancet 2000; 356: 1464-1469.
26. Day RW, Hawkins JA, McGough EC, Crezee KL, Orsmond GS. Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 2000; 69: 1907-1912; discussion 1913.
27. Atz AM, Adatia I, Wessel DL. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 1996; 62: 1759-1764.
28. Miller OI, Tang SF, Keech A, Celermajer DS. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 1995; 346 (8966): 51-52.
29. Namachivayam P, Theilen U, Butt WW, Cooper SM, Penny DJ, Shekerdemian LS. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 2006; 174: 1042-1047.
30. Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation 2005; 111: 3274-3280.
31. Ikonomidis JS, Hilton EJ, Payne K, et al. Selective endothelin-A receptor inhibition after cardiac surgery: A safety and feasibility study. Ann Thorac Surg 2007; 83: 2153-2160; discussion 2161.
32. Barr FE, Tirona RG, Taylor MB, et al. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: Potential therapy for post-operative pulmonary hypertension. J Thorac Cardiovasc Surg 2007; 134: 319-326.